Example: Heart Attack
Clinical Trials Sponsored by Dr Gisèle PICKERING (MCU-PH)(Clinical Pharmacology center, Inserm 501)
Total 1 results
-
NCT01935570Completed
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- Hospital, Vannes
- Amphia Hospital
- Assistance Publique - Hôpitaux de Paris
- Assiut University
- National Cancer Institute (NCI)
- Pfizer
- Novartis Pharmaceuticals
- John Kempen
- M.D. Anderson Cancer Center
- BKK Mobil Oil
- Mayo Clinic
- AstraZeneca
- Cairo University
- Beijing DMS Pharma Ltd.
- Mid-Atlantic Nutrition Obesity Research Center
- First Hospital of Shijiazhuang City
- Charlotte Gastroenterology and Hepatology
- Groupe Pasteur Mutualité
- Universitätsklinikum Tulln
- GlaxoSmithKline
- View Full List
Medical Conditions
- Blood Flow Indexes
- Hypertension
- Gastroesophageal Reflux Disease With Dyspepsia Symptoms
- Leucocytosis
- Pain
- Nutritional Status in Hospitalised Geriatric Patients
- Prostate Cancer
- Depression
- HIV Infections
- Stroke
- Blood Coagulation Disorder Due to Liver Disease
- Obesity
- ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia
- Coronary Artery Disease
- Infection Gastrointestinal
- Asthma
- Corpus Callosum Malformation
- Pre-terminal Cancer
- Breast Cancer
- Hematopoietic and Lymphoid Cell Neoplasm
- View Full List
Drug Interventions
- Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
- Gemcitabine
- enalapril and other angiotensin converting enzyme inhibitors; losartan and other angiotensin receptor blockers
- Prednisone
- Cisplatin
- AC-150A 0.1%
- Capecitabine
- Dexamethasone
- Dicofenac
- Cyclophosphamide
- 100 mg INX-08189 QD
- docetaxel
- Triamcinolone Acetonide 4 mg intravitreal injection
- CA-008
- Carboplatin
- Paclitaxel
- Iodixanol, Ioversol, Iopromide
- Efficacy of Enbrel subcutaneously at Week 36
- M4344 10 mg BIW
- Bevacizumab
- View Full List
CROs by country
- Contract Research Organizations in Benin
- Contract Research Organizations in China
- Contract Research Organizations in Egypt
- Contract Research Organizations in India
- Contract Research Organizations in Japan
- Contract Research Organizations in Kenya
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mexico
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Russia
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Switzerland
- CRO list by country